Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
0.91
Jun. 23, 2025 16:00:00- Change 0.0241 (2.70787%)
- Volume 150,062
- Today's Open 0.89
- Previous Close 0.89
- Today's High 0.93
- Today's Low 0.89
- 52 Week High 4.3
- 52 Week Low 0.85